Fortunately, there are many alternatives that help you save the cost of this and keep living comfortably throughout the coldest months of the year. In this post, you will find a list of the six most ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. If investing in a company came down to size, the stock would be a no-brainer buy. However ...

The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 consecutive years, making it a Dividend King. Between Johnson & Johnson's strong ...

Johnson & Johnson (NYSE: JNJ) has a diverse healthcare business, and investors often look to it as a safe dividend stock to invest in for the long term. One area where it has been lacking ...

Here's the skinny on that quarter and whether the rest of the year will be healthy enough to rank the company's stock as a buy. To give some idea of the sheer size of Johnson & Johnson ...

Could now be the time to invest in this struggling healthcare stock? Johnson & Johnson to acquire Intra-Cellular Therapies On Jan. 13, Johnson & Johnson announced plans to acquire Intra-Cellular ...

The stock has a dividend yield of 3.26%, as of January 30. Insider Monkey’s database of Q3 2024 indicated that 81 hedge funds held stakes in Johnson & Johnson (NYSE:JNJ), up from 80 in the ...

JOUT shares fell after reporting Q4 results. Sales grew but missed expectations, gross margin decreased due to discounts & product mix.